Search by Drug Name or NDC

    NDC 31722-0591-01 METOPROLOL SUCCINATE 100 mg/1 Details

    METOPROLOL SUCCINATE 100 mg/1

    METOPROLOL SUCCINATE is a ORAL TABLET, FILM COATED, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Camber Pharmaceuticals, Inc.. The primary component is METOPROLOL SUCCINATE.

    Product Information

    NDC 31722-0591
    Product ID 31722-591_f57120d2-136e-b289-e053-2995a90ad0b8
    Associated GPIs 33200030057530
    GCN Sequence Number 016600
    GCN Sequence Number Description metoprolol succinate TAB ER 24H 100 MG ORAL
    HIC3 J7C
    HIC3 Description BETA-ADRENERGIC BLOCKING AGENTS
    GCN 20742
    HICL Sequence Number 006323
    HICL Sequence Number Description METOPROLOL SUCCINATE
    Brand/Generic Generic
    Proprietary Name METOPROLOL SUCCINATE
    Proprietary Name Suffix n/a
    Non-Proprietary Name METOPROLOL SUCCINATE
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 100
    Active Ingredient Units mg/1
    Substance Name METOPROLOL SUCCINATE
    Labeler Name Camber Pharmaceuticals, Inc.
    Pharmaceutical Class Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA205541
    Listing Certified Through 2024-12-31

    Package

    NDC 31722-0591-01 (31722059101)

    NDC Package Code 31722-591-01
    Billing NDC 31722059101
    Package 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (31722-591-01)
    Marketing Start Date 2020-11-06
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.10542
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description METOPROLOL SUCC ER 100 MG TAB
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis